ITMCTR1900002399尚未招募4 期
Clinical efficacy of arsenic trioxide combined with carboplatin for neoadjuvant chemotherapy for locally advanced cervical cancer
The First Affiliated Hospital of Guangzhou University of Chinese Medicine0 个研究点开始时间: 待定最近更新:
适应症
试验速览
- 阶段
- 4 期
- 状态
- 尚未招募
- 发起方
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional study
入排标准
- 年龄范围
- 20 至 60（—）
- 性别
- Female
入选标准
- •1 Aged 20-60 years;
- •2 Patients with stage IB2, IIA2, IIB cervical cancer;
- •3 Normal blood analysis, liver and kidney function before treatment;
- •4 No evidence of distant metastasis;
- •5 No serious heart, liver, kidney and blood system and other important organ diseases;
- •6 Patients have signed the informed consent
排除标准
- •1 Early or small lesions do not require neoadjuvant chemotherapy patients;
- •2 cachexia:PS score = 3 points, KPS score < 70 points;
- •3 Active infection or bleeding;
- •4 Complete intestinal obstruction;
- •5 Uncontrolled psychosis;
- •6 Pregnant and lactating women;
- •7 Allergic constitution, or known to arsenic allergy patients;
- •8 Late no possibility of surgery patients;
- •9 Patients who are unwilling to receive neoadjuvant chemotherapy combined with surgery in the advanced stage;
- •10 Patients with severe comorbidities;
- •11 Patients who cannot tolerate chemotherapy and surgical words; 13 Patients who have participated in other clinical trials in the last 3 months;
- •12 Any other conditions that the investigator considers unsuitable for participation in this trial.
研究者
相似试验
已完成
3 期
Effect of arsenic trioxide in induction of complete remission of acute myeloid leukemia(non m3)Acute myeloblastic leukemiaIRCT20140818018842N16Hematology, Oncology & Stem Cell Transplantation Research Center, Tehran University of Medical Sci.112
进行中（未招募）
2 期
Multicenter, phase II study of arsenic trioxide and all-trans retinoic acid in patients with newly diagnosed acute promyelocytic leukemia in Japan (JALSG-APL220)D015473acute promyelocytic leukemiaJPRN-jRCTs041200102Yokoyama Yasuhisa99
Unknown
2 期
Arsenic Trioxide TACE and Intravenous Administration in Unresectable Hepatocellular CarcinomaCarcinoma, HepatocellularNCT01861912Guangdong Provincial People's Hospital258
已完成
1 期
Arsenic Trioxide in Combination With Cytarabine in Patients With High-risk MDS and Poor-prognosis AMLMyelodysplastic SyndromeNCT00195104Weill Medical College of Cornell University87
Unknown
不适用
Treatment of Aplastic AnemiaCTRI/2013/03/003480Principal Investigator Research Fund20